{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:00:26Z","timestamp":1780732826398,"version":"3.54.1"},"publisher-location":"Cham","reference-count":27,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031898433","type":"print"},{"value":"9783031898440","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":190,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Purpose:<\/jats:italic>\n                    Intravenous and intra-arterial milrinone as a rescue measure for delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH) has been adopted by several groups, but so far, evidence for the clinical benefit is unclear and the effect on brain perfusion is contradictory. We recently published our experience with intravenous milrinone as a rescue strategy for DCI. The aim of the actual analysis was to contextualize our experience with the currently available evidence from clinical trials on the effect of intravenous milrinone in preventing or treating DCI following aneurysmal SAH.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Methods:<\/jats:italic>\n                    PubMed was searched for clinical studies using intravenous milrinone for the prevention or treatment of DCI after aneurysmal subarachnoid hemorrhage.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results:<\/jats:italic>\n                    In our series, using intravenous milrinone as a rescue strategy together with using norepinephrine to elevate blood pressure, improvements in cerebral perfusion as measured by perfusion computed tomography (CT) and in clinical symptoms were seen after the induction of rescue therapy. At long-term follow-up, patients suffering DCI had only modestly worse outcomes than patients not suffering DCI. The PubMed search provided four comparative clinical studies. In a preventive setup, Soliman et al. compared intravenous milrinone with magnesium. The incidence of cerebral vasospasm was significantly lower and patients\u2019 neurological condition in terms of the Glasgow Coma Scale (GCS) better with magnesium compared to milrinone. Milrinone was associated with hypotension and the need for dopamine and norepinephrine. Rouanet et al. compared milrinone with norepinephrine as a rescue strategy. They found that transcranial Doppler (TCD) flow velocities decreased after milrinone therapy only, not after norepinephrine, whereas clinical improvement was achieved with both treatment strategies. Labeyrie et al. compared balloon angioplasty plus intravenous milrinone with induced hypertension alone. They did not find any significant differences regarding the outcomes. Finally, Lakhal and coauthors compared intravenous milrinone plus induced hypertension as a rescue strategy, where a historical control group received induced hypertension alone. Milrinone was associated with a lower rate of additional endovascular angioplasty and a positive impact on long-term neurological and radiological outcomes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion:<\/jats:italic>\n                    Our study showed that cerebral perfusion in the setting of secondary cerebral ischemia following SAH is measurably improved via intravenous milrinone and norepinephrine-based hyperdynamic therapy. In the context of the available literature, when used as a rescue strategy, milrinone appears to be beneficial if additional norepinephrine is given to maintain adequate arterial pressure.\n                  <\/jats:p>","DOI":"10.1007\/978-3-031-89844-0_1","type":"book-chapter","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T09:46:08Z","timestamp":1752140768000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Evidence for Intravenous Milrinone to Treat Secondary Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage\u2014A Narrative Review"],"prefix":"10.1007","author":[{"given":"Hans-Jakob","family":"Steiger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Andereggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Marbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2020.1.JNS193107","volume":"27","author":"YB Abulhasan","year":"2020","unstructured":"Abulhasan YB, Ortiz Jimenez J, Teitelbaum J, Simoneau G, Angle MR. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia. J Neurosurg. 2020;27:1\u201312. https:\/\/doi.org\/10.3171\/2020.1.JNS193107. Epub ahead of print. PMID: 32217799","journal-title":"J Neurosurg"},{"issue":"11","key":"1_CR2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJM198303173081103","volume":"308","author":"GS Allen","year":"1983","unstructured":"Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DP, Hundley MB, Johnson RK, Strom JA, Transou CR. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 1983;308(11):619\u201324. https:\/\/doi.org\/10.1056\/NEJM198303173081103. PMID: 6338383","journal-title":"N Engl J Med"},{"issue":"4","key":"1_CR3","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1097\/00006123-200104000-00004","volume":"48","author":"Y Arakawa","year":"2001","unstructured":"Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48(4):723\u20138; discussion 728\u201330. https:\/\/doi.org\/10.1097\/00006123-200104000-00004. PMID: 11322432","journal-title":"Neurosurgery"},{"issue":"2","key":"1_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192832","volume":"13","author":"S Bercker","year":"2018","unstructured":"Bercker S, Winkelmann T, Busch T, Laudi S, Lindner D, Meixensberger J. Hydroxyethyl starch for volume expansion after subarachnoid haemorrhage and renal function: results of a retrospective analysis. PLoS One. 2018;13(2):e0192832. https:\/\/doi.org\/10.1371\/journal.pone.0192832. PMID: 29447255; PMCID: PMC5813956","journal-title":"PLoS One"},{"issue":"3","key":"1_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ANA.0000000000000755","volume":"33","author":"TD Bernier","year":"2021","unstructured":"Bernier TD, Schontz MJ, Izzy S, Chung DY, Nelson SE, Leslie-Mazwi TM, Henderson GV, Dasenbrock H, Patel N, Aziz-Sultan MA, Feske S, Du R, Abulhasan YB, Angle MR. Treatment of subarachnoid hemorrhage-associated delayed cerebral ischemia with milrinone: a review and proposal. J Neurosurg Anesthesiol. 2021;33(3):195\u2013202. https:\/\/doi.org\/10.1097\/ANA.0000000000000755. PMID: 33480639; PMCID: PMC8192346","journal-title":"J Neurosurg Anesthesiol"},{"issue":"6","key":"1_CR6","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s10143-021-01509-1","volume":"44","author":"M Castle-Kirszbaum","year":"2021","unstructured":"Castle-Kirszbaum M, Lai L, Maingard J, Asadi H, Danks RA, Goldschlager T, Chandra RV. Intravenous milrinone for treatment of delayed cerebral ischaemia following subarachnoid haemorrhage: a pooled systematic review. Neurosurg Rev. 2021;44(6):3107\u201324. https:\/\/doi.org\/10.1007\/s10143-021-01509-1. Epub 2021 Mar 8. PMID: 33682040","journal-title":"Neurosurg Rev"},{"issue":"3","key":"1_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/ANA.0000000000000527","volume":"31","author":"T Crespy","year":"2019","unstructured":"Crespy T, Heintzelmann M, Chiron C, Vinclair M, Tahon F, Francony G, Payen JF. Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid Hemorrhage? J Neurosurg Anesthesiol. 2019;31(3):323\u20139. https:\/\/doi.org\/10.1097\/ANA.0000000000000527. PMID: 30015694","journal-title":"J Neurosurg Anesthesiol"},{"issue":"6","key":"1_CR8","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P, American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke. 2012;43(6):1711\u201337. https:\/\/doi.org\/10.1161\/STR.0b013e3182587839. Epub 2012 May 3. PMID: 22556195","journal-title":"Stroke"},{"issue":"7","key":"1_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1089\/neu.2012.2573","volume":"30","author":"DJ Cooper","year":"2013","unstructured":"Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, Murray L, Vallance S, SAFE-TBI Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma. 2013;30(7):512\u20138. https:\/\/doi.org\/10.1089\/neu.2012.2573. Epub 2013 Mar 21. PMID: 23194432; PMCID: PMC3636581","journal-title":"J Neurotrauma"},{"issue":"3","key":"1_CR10","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","volume":"39","author":"AT Fraticelli","year":"2008","unstructured":"Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39(3):893\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.107.492447. Epub 2008 Jan 31. PMID: 18239182","journal-title":"Stroke"},{"issue":"7","key":"1_CR11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.2916","volume":"10","author":"N Katyal","year":"2018","unstructured":"Katyal N, George P, Nattanamai P, Raber LN, Beary JM, Newey CR. Improvement in sonographic vasospasm following intravenous milrinone in a subarachnoid hemorrhage patient with normal cardiac function. Cureus. 2018;10(7):e2916. https:\/\/doi.org\/10.7759\/cureus.2916. PMID: 30186721; PMCID: PMC6122655","journal-title":"Cureus"},{"issue":"2","key":"1_CR12","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/00006123-199702000-00025","volume":"40","author":"K Khajavi","year":"1997","unstructured":"Khajavi K, Ayzman I, Shearer D, Jones SC, Levy JH, Prayson RA, Skibinski CI, Hahn JF, Chyatte D. Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery. 1997;40(2):354\u201362; discussion 362\u20133. https:\/\/doi.org\/10.1097\/00006123-199702000-00025. PMID: 9007870","journal-title":"Neurosurgery"},{"issue":"10","key":"1_CR13","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s00701-021-04935-8","volume":"163","author":"MA Labeyrie","year":"2021","unstructured":"Labeyrie MA, Simonato D, Gargalas S, Morisson L, Cortese J, Ganau M, Fuschi M, Patel J, Froelich S, Gaugain S, Chousterman B, Houdart E. Intensive therapies of delayed cerebral ischemia after subarachnoid hemorrhage: a propensity-matched comparison of different center-driven strategies. Acta Neurochir (Wien). 2021;163(10):2723\u201331. https:\/\/doi.org\/10.1007\/s00701-021-04935-8. Epub 2021 Jul 24. PMID: 34302553","journal-title":"Acta Neurochir (Wien)"},{"key":"1_CR14","doi-asserted-by":"publisher","unstructured":"Lakhal K, Hivert A, Alexandre PL, Fresco M, Robert-Edan V, Rodie-Talbere PA, Ambrosi X, Bourcier R, Rozec B, Cadiet J. Intravenous milrinone for cerebral vasospasm in subarachnoid Hemorrhage: the MILRISPASM controlled before-after study. Neurocrit Care. 2021; https:\/\/doi.org\/10.1007\/s12028-021-01331-z. Epub ahead of print. PMID: 34478028","DOI":"10.1007\/s12028-021-01331-z"},{"issue":"1\u20132","key":"1_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000445509","volume":"42","author":"N Matsuda","year":"2016","unstructured":"Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, Hasegawa S, Takemura A. Effect of cilostazol on cerebral vasospasm and outcome in patients with aneurysmal subarachnoid Hemorrhage: a randomized, double-blind, Placebo-Controlled Trial. Cerebrovasc Dis. 2016;42(1\u20132):97\u2013105. https:\/\/doi.org\/10.1159\/000445509. Epub 2016 Apr 13. PMID: 27070952","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"1_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3171\/2011.8.JNS101767","volume":"116","author":"CG McDougall","year":"2012","unstructured":"McDougall CG, Spetzler RF, Zabramski JM, Partovi S, Hills NK, Nakaji P, Albuquerque FC. The Barrow ruptured aneurysm trial. J Neurosurg. 2012;116(1):135\u201344. https:\/\/doi.org\/10.3171\/2011.8.JNS101767. Epub 2011 Nov 4. PMID: 22054213","journal-title":"J Neurosurg"},{"key":"1_CR17","volume-title":"Phosphodiesterase inhibitors","author":"IS Padda","year":"2023","unstructured":"Padda IS, Tripp J. Phosphodiesterase inhibitors. Treasure Island: StatPearls Publishing [Internet]; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559276\/."},{"issue":"6","key":"1_CR18","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3171\/jns.2005.103.6.0974","volume":"103","author":"A Raabe","year":"2005","unstructured":"Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2005;103(6):974\u201381. https:\/\/doi.org\/10.3171\/jns.2005.103.6.0974. PMID: 16381183","journal-title":"J Neurosurg"},{"key":"1_CR19","doi-asserted-by":"publisher","unstructured":"Rouanet C, Chaddad F, Freitas F, Miranda M, Vasconcellos N, Valiente R, Muehlschlegel S, Silva GS. Kinetics of cerebral blood flow velocities during treatment for delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2021; https:\/\/doi.org\/10.1007\/s12028-021-01288-z. Epub ahead of print. PMID: 34286467","DOI":"10.1007\/s12028-021-01288-z"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1227\/00006123-198306000-00012","volume":"12","author":"RH Rosenwasser","year":"1983","unstructured":"Rosenwasser RH, Delgado TE, Buchheit WA, Freed MH. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: a preliminary report. Neurosurgery. 1983;12:658\u201361.","journal-title":"Neurosurgery"},{"issue":"4","key":"1_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ccr3.2034","volume":"7","author":"AG Santos-Teles","year":"2019","unstructured":"Santos-Teles AG, Passos RH, Panerai RB, Ramalho C, Farias S, Rosa JG, Gobatto A, Benigno P, Caldas JR. Intravenous administration of milrinone, as an alternative approach to treat vasospasm in subarachnoid hemorrhage: a case report of transcranial Doppler monitoring. Clin Case Rep. 2019;7(4):648\u201352. https:\/\/doi.org\/10.1002\/ccr3.2034. PMID: 30997055; PMCID: PMC6452455","journal-title":"Clin Case Rep"},{"issue":"1","key":"1_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","volume":"118","author":"N Senbokuya","year":"2013","unstructured":"Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, Shimizu T, Furuya K, Uchida M, Takeuchi N, Nakano S, Koizumi H, Kobayashi C, Fukasawa I, Takahashi T, Kuroda K, Nishiyama Y, Yoshioka H, Horikoshi T. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial. J Neurosurg. 2013;118(1):121\u201330. https:\/\/doi.org\/10.3171\/2012.9.JNS12492. Epub 2012 Oct 5. PMID: 23039152","journal-title":"J Neurosurg"},{"issue":"4","key":"1_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","volume":"76","author":"M Shibuya","year":"1992","unstructured":"Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76(4):571\u20137. https:\/\/doi.org\/10.3171\/jns.1992.76.4.0571. PMID: 1545249","journal-title":"J Neurosurg"},{"key":"1_CR24","doi-asserted-by":"publisher","unstructured":"Soliman R, Zohry G. Efeitos do sulfato de magn\u00e9sio e da milrinona sobre o vasoespasmo cerebral ap\u00f3s hemorragia subaracnoidea por aneurisma: estudo rand\u00f4mico [Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study]. Braz J Anesthesiol. 2019;69(1):64\u201371. Portuguese. https:\/\/doi.org\/10.1016\/j.bjan.2018.09.005. Epub 2018 Nov 6. PMID: 30409409.","DOI":"10.1016\/j.bjan.2018.09.005"},{"issue":"3","key":"1_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00701-022-05145-6","volume":"164","author":"HJ Steiger","year":"2022","unstructured":"Steiger HJ, Ensner R, Andereggen L, Remonda L, Berberat J, Marbacher S. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. Acta Neurochir. 2022;164(3):811\u201321. https:\/\/doi.org\/10.1007\/s00701-022-05145-6.","journal-title":"Acta Neurochir"},{"issue":"2","key":"1_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/MCC.0b013e32832922d1","volume":"15","author":"MM Treggiari","year":"2009","unstructured":"Treggiari MM, Deem S. Which H is the most important in triple-H therapy for cerebral vasospasm? Curr Opin Crit Care. 2009;15(2):83\u20136. https:\/\/doi.org\/10.1097\/MCC.0b013e32832922d1. PMID: 19276798","journal-title":"Curr Opin Crit Care"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"164597","DOI":"10.1155\/2015\/164597","volume":"2015","author":"FA Zeiler","year":"2015","unstructured":"Zeiler FA, Silvaggio J. Early angiographic resolution of cerebral vasospasm with high dose intravenous milrinone therapy. Case Rep Crit Care. 2015;2015:164597. https:\/\/doi.org\/10.1155\/2015\/164597. Epub 2015 Sep 17. PMID: 26457209; PMCID: PMC4589610","journal-title":"Case Rep Crit Care"}],"container-title":["Acta Neurochirurgica Supplement","Trends in the Treatment of Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-89844-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:28:08Z","timestamp":1780730888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-89844-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031898433","9783031898440"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-89844-0_1","relation":{},"ISSN":["0065-1419","2197-8395"],"issn-type":[{"value":"0065-1419","type":"print"},{"value":"2197-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"10 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Conflicts of interests:\n                      \u2002The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Compliance with ethical standards\n                      :\u2002The information shared is not based on human studies and\/or animal studies. The analysis was conceived as a quality assessment based on existing data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EJCVC","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"European \u2013 Japanese Cerebrovascular Congress","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Kyoto","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Japan","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2022","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"13 November 2022","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 November 2022","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"ejcvc2022","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/site.convention.co.jp\/ejcvc2020\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}